Related Experiment Video
Updated: May 1, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Target product profiles for new diagnostics to inform strongyloidiasis control programs.
Adama Kazienga1,2, Luc E Coffeng2, Sara Roose1
1Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.
New diagnostics for strongyloidiasis should prioritize high specificity. A prototype lateral flow assay (LFA) offers a cost-effective alternative to the Baermann method for deworming programs.
Area of Science:
- Medical Diagnostics
- Parasitology
- Public Health
Background:
- The World Health Organization emphasizes the need for new diagnostics to support strongyloidiasis deworming programs.
- Target Product Profiles (TPPs) are crucial for guiding research and development (R&D) of new diagnostics.
- Currently, diagnostic TPPs are lacking for strongyloidiasis, unlike other soil-transmitted helminthiases.
Purpose of the Study:
- To establish minimal requirements for new strongyloidiasis diagnostics by investigating potential Target Product Profiles (TPPs).
- To assess the impact of diagnostic performance, cost, and throughput on program decision-making and survey costs.
- To compare the cost-efficiency of different diagnostic platforms and survey designs for strongyloidiasis control.
Main Methods:
- Utilized a simulation framework to evaluate the effect of imperfect diagnostics on program costs and decisions.
- Investigated requirements for diagnostic performance, cost per test, and sample throughput for future assays.
- Compared survey costs of potential assays (antibody-detecting assays, lateral flow assay (LFA), Ab-ELISA) against the reference Baermann method.
- Determined cost-efficient school-based survey designs for Bordier Ab-ELISA and a prototype NIE-LFA.
Main Results:
- Assay specificity is more critical than sensitivity for R&D in diagnostic methods for control programs.
- Diagnostic performance requirements became less stringent with larger sample sizes and higher acceptance of incorrect decision-making.
- Lateral flow assays (LFAs) demonstrated lower survey costs compared to the Baermann method.
- The prototype NIE-LFA facilitated the most cost-efficient survey designs among the evaluated assays.
Conclusions:
- Future R&D should prioritize the development of point-of-care assays with high specificity for strongyloidiasis.
- The prototype NIE-LFA presents a cost-effective alternative to the Baermann method, supporting strongyloidiasis control programs.
Related Concept Videos
Antibiotic Selection
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Production of Antibiotics
Automated Microbial Diagnostics

